Having trouble accessing articles? Reset your cache.

Tetrodotoxin: Phase III ongoing

Wex said that a DMC informed the company that the ongoing double-blind, placebo-controlled, Canadian Phase III TEC-006

Read the full 179 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE